Cash and code: insurance battles, AI drugs, and out-of-pocket health

Healthcare is a mess to pay for, but tech and new science are still pushing therapies to market, often bypassing traditional routes.

1. Erosion of insurance access

As federal subsidies dry up, more people lose insurance. This shifts the financial burden onto hospitals and individuals, driving up out-of-pocket costs and making care, especially for conditions like chronic pain and mental health, less accessible.

Expect more direct-to-consumer health services that bypass insurance altogether. Also, watch for increased state-level pressure on corporations to cover employee health costs.

Evidence from today:

• Hospital chain HCA expects $1B less profit from uninsured patients — Large for-profit hospital operator HCA Holdings expects a $1 billion hit to profits. More patients are losing insurance coverage as post-pandemic Affordable Care Act (ACA) subsidies dry up. This means higher costs for hospitals and potentially less access to care for people, especially for mental health services that often rely on insurance.
• States pressure big businesses over employees on Medicaid — As federal Medicaid work requirements approach, states are pushing back on large corporations like Amazon and Walmart whose employees rely on the safety net health program. Democrats are eyeing legislation to make these companies financially accountable for their low-wage workers' healthcare costs. This isn't just about dollars, it's about the very real impact of precarious work on health.

2. Beyond GLP-1 for metabolic health

The success of GLP-1 drugs has spurred investment in alternative pathways for obesity and metabolic health. Companies are now exploring non-GLP-1 mechanisms, signaling a diversification in drug development aimed at tackling a widespread health issue.

The metabolic drug landscape will get more crowded and complex. Keep an eye out for novel targets that might offer different side effect profiles or efficacy for non-responders to GLP-1s.

Evidence from today:

• Mywyngil Therapeutics chases obesity drug without GLP-1 target — Mywyngil Therapeutics just raised seed funding to develop obesity drugs that don't target GLP-1. The startup is betting on a new mechanism to improve metabolic health beyond the current blockbuster drugs.
• Anthropic's Claude Science AI aims at Kendall Square biotech — Anthropic is bringing its new Claude Science AI to Kendall Square, signaling a major move into biotech research. This AI, designed for complex scientific data, means pharma and biotech firms will soon get highly detailed, rapid insights. It could accelerate drug discovery and research, changing how new therapies hit the market.

3. DIY health tracking and treatment

People are seeking greater control and transparency in their health data and access to care. This leads to the rise of direct-to-consumer lab testing and the integration of tech for conditions like chronic pain, bypassing traditional, often opaque, healthcare systems.

The market for personal health tech and services not tied to insurance will grow. For individuals, this means more options, but also greater responsibility for interpreting data and vetting solutions.

Evidence from today:

• Mito Health launches transparent lab testing — Mito Health launched a new service offering direct-to-consumer lab testing with upfront pricing. The platform lets users order specific tests like hormone panels or metabolic markers without insurance, aiming for clear costs. This targets people who want to track their health data without hidden fees.
• Clair raises $11.6M for hormone-tracking wearable to launch soon — Jenny Duan, 22, secured $11.6 million for Clair, her continuous hormone-tracking wearable. The device aims to disrupt women's health by offering real-time insights into hormonal fluctuations, moving beyond cycle tracking.
• XR Health buys Swing Therapeutics for digital fibromyalgia treatment — Medical virtual reality platform XR Health acquired Swing Therapeutics, known for its digital therapeutic prescription for fibromyalgia. This move integrates Swing's digital treatment for chronic pain into XR Health's existing VR-based therapy offerings. It signals a continued push towards non-pharmacological, tech-driven solutions for complex, nervous-system-related conditions.

4. Environmental impact on health

Climate change and environmental decline are increasingly recognized as direct drivers of economic instability and global health crises. This extends beyond physical health to significant mental health challenges, reflecting a direct link between planetary health and human well-being.

Expect policymakers and healthcare providers to start integrating environmental factors into health assessments and strategic planning. This isn't just about 'green' initiatives; it's about avoiding disaster.

Evidence from today:

• New report links climate crisis to economic, global health disaster — A new Nature News report suggests the global economy is heading for a 'climate free fall', directly linking environmental collapse to severe economic instability. The report highlights how this instability could lead to widespread health crises, including increased mental health challenges and chronic disease. It's a wake-up call for policymakers and individuals that economic forecasts aren't factoring in the true bodily cost of a warming planet.
• States pressure big businesses over employees on Medicaid — As federal Medicaid work requirements approach, states are pushing back on large corporations like Amazon and Walmart whose employees rely on the safety net health program. Democrats are eyeing legislation to make these companies financially accountable for their low-wage workers' healthcare costs. This isn't just about dollars, it's about the very real impact of precarious work on health.

Also moved today

• FDA biologics center tries to calm waters after leadership turmoil (STAT News) — FDA biologics leadership changes could mean delays or reprioritization for vaccines and gene therapies hitting the market.
• AI's top beauty picks are ingredient-focused skincare brands (Glossy) — AI's preference for ingredient-focused skincare brands suggests it values transparency and established scientific claims in beauty recommendations.
• Farmented Foods turns 'ugly' produce into fermented gut-health products (New Hope Network (Natural Products Expo)) — Farmented Foods turning 'ugly' produce into gut-health products taps into both sustainability concerns and the functional food trend.
• Movement breaks relieve stress, improve focus for WFH (Mindbodygreen) — Short movement breaks during work reduce stress and improve focus by regulating the nervous system, offering a low-effort way to boost well-being.

What I'd watch next

Keep an eye on how state governments enforce corporate accountability for employee healthcare costs and the specific outcomes of new FDA leadership on biologics approval timelines. Also, watch for the first non-GLP-1 metabolic drugs entering human trials.